(Q68581527)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2226501%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

title

In vitro activity of the new semi-synthetic polypeptide cilofungin (LY121019) against Aspergillus and Candida species (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2226501%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

author name string

A Huang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2226501%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

F Edwards

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2226501%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

E M Bernard

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2226501%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

D Armstrong

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2226501%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

H J Schmitt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2226501%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

publication date

1 September 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2226501%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Microbiology & Infectious Diseases

25 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2226501%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2226501%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2226501%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

page(s)

697-699

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2226501%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01964276

25 September 2019

exact match

0 references

cites work

In vitro and in vivo anti-Candida activity and toxicology of LY121019

1 reference

12 December 2020

Amphotericin B or ketoconazole therapy of fungal infections in neutropenic cancer patients

1 reference

12 December 2020

Testing of organisms for susceptibility to triazoles: is it justified?

1 reference

12 December 2020

Effects of cilofungin (LY121019) on carbohydrate and sterol composition of Candida albicans

1 reference

12 December 2020

Antifungal susceptibility tests

1 reference

12 December 2020

Treatment of experimental disseminated candidiasis with cilofungin

1 reference

12 December 2020

Comparative effects of cilofungin and amphotericin B on experimental murine candidiasis

1 reference

12 December 2020

Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy

1 reference

12 December 2020

Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods

1 reference

12 December 2020

Papulacandin B: an Inhibitor of Glucan Synthesis in Yeast Spheroplasts

1 reference

12 December 2020

Comparative in vitro activity of LY121019 and amphotericin B against clinical isolates of Candida species

1 reference

12 December 2020

Evaluation of cilofungin (LY121019) for treatment of experimental Candida albicans endocarditis in rabbits

1 reference

12 December 2020

Aspergillosis complicating neoplastic disease

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01964276

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2226501%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

1 reference